1 completed, 1 terminated, 1 unknown. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 1, Terminated 1, Unknown 1 |
| Phase 2 | 1 | Completed 1 |
Follow CMV Viremia: new trials by email Literature Review of CMV Viremia trials Research Report on CMV Viremia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Expansion of Virus-Specific Lymphocytes for Cell Therapy Lymphocyte infusion (ImmuneCellVir-I) - CMV Viremia, CMV | Phase 1 | Unknown | Hospital Israelita Albert Einstein | 10 | 2024-06-10 | 2024-10-24 |
| Treatment of Cytomegalovirus (CMV) Infections With Viral-Specific T Cells CMV-specific T-cells - CMV Infection, Cytomegalovirus Infections | Phase 1 | Terminated | University of Wisconsin, Madison | 3 | 2020-02-06 | 2024-10-31 |
| Virus-specific Activated T Lymphocytes From a Donor in Hematopoietic Progenitor Transplanted Patients Activated T-Lymphocytes - CMV Viremia, Immunosuppression-related Infectious Disease | Phase 1 / Phase 2 | Completed | Banc de Sang i Teixits | 26 | 2019-07-04 | 2024-01-24 |
Cytomegalovirus Infections (1) · Opportunistic Infections (1) · Virus Diseases (1)
Infections (2) · DNA Virus Infections (1) · Herpesviridae Infections (1) · Virus Diseases (1)
Banc de Sang i Teixits (1) · Hospital Israelita Albert Einstein (1) · University of Wisconsin, Madison (1)
Brazil (1) · Spain (1) · United States (1)
Christain Capitini, MD (1) · Jacques Galipeau, MD (1) · Nelson Hamerschlak, MD, PhD (1) · Pere Barba, MD, PhD (1)